Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06603506
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-06
Brief Title:
Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors PENDOR Pilot Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors PENDOR Pilot Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PENDOR
Brief Summary:
This study comprises 3 stages
1 Collection of tumor and blood samples
2 Creation of organoid models based on tumor samples
3 Development of functional tests to predict clinical response to treatment
1 Collection of tumor and blood samples
2 Creation of organoid models based on tumor samples
3 Development of functional tests to predict clinical response to treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None